Shenzhen - Delayed Quote CNY

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)

11.97 +0.20 (+1.70%)
At close: April 26 at 3:04 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,682,065.51
2,336,229.84
2,968,050.84
2,363,785.86
Cost of Revenue
1,177,123.16
1,298,450.32
1,241,217.69
740,653.32
Gross Profit
504,942.36
1,037,779.52
1,726,833.15
1,623,132.54
Operating Expense
736,854.86
902,094.73
1,389,445.67
1,241,639.38
Operating Income
-231,912.51
135,684.79
337,387.48
381,493.16
Net Non Operating Interest Income Expense
-105,847.40
-100,940.28
-68,147.82
-59,923.87
Pretax Income
-472,516.37
18,116.31
260,409.60
301,557.13
Tax Provision
-26,492.99
7,960.21
29,148.07
50,416.61
Net Income Common Stockholders
-438,106.62
17,513.46
233,573.84
252,842.32
Basic EPS
-0.47
0.02
0.25
0.27
Diluted EPS
-0.47
0.02
0.25
0.27
Basic Average Shares
848,162.27
875,673.22
934,295.36
936,453.02
Diluted Average Shares
848,162.27
875,673.22
934,295.36
936,453.02
Total Operating Income as Reported
-472,032.67
20,452.54
261,999.18
309,196.82
Total Expenses
1,913,978.02
2,200,545.05
2,630,663.36
1,982,292.70
Net Income from Continuing & Discontinued Operation
-438,106.62
17,513.46
233,573.84
252,842.32
Normalized Income
-305,043.19
33,253.24
236,099.11
257,759.81
Interest Income
1,827.75
1,993.82
1,303.40
1,639.62
Interest Expense
101,176.16
93,043.17
62,294.86
55,805.66
Net Interest Income
-105,847.40
-100,940.28
-68,147.82
-59,923.87
EBIT
-371,340.20
111,159.47
322,704.46
357,362.79
EBITDA
-371,340.20
168,095.13
378,505.23
412,643.47
Reconciled Cost of Revenue
1,177,123.16
1,298,450.32
1,241,217.69
740,653.32
Reconciled Depreciation
--
56,935.66
55,800.78
55,280.68
Net Income from Continuing Operation Net Minority Interest
-438,106.62
17,513.46
233,573.84
252,842.32
Total Unusual Items Excluding Goodwill
-140,967.16
-20,986.37
-2,843.55
-5,904.68
Total Unusual Items
-140,967.16
-20,986.37
-2,843.55
-5,904.68
Normalized EBITDA
-230,373.04
189,081.51
381,348.79
418,548.16
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-7,903.73
-5,246.59
-318.28
-987.19
12/31/2020 - 8/19/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CNTA Centessa Pharmaceuticals plc
8.92
-0.11%
 
NMRA Neumora Therapeutics, Inc.
9.15
+0.99%
 
UCB.BR UCB SA
124.55
+0.65%
 
GLYC GlycoMimetics, Inc.
1.6400
-4.09%
 
CGON CG Oncology, Inc.
41.00
+13.26%
 
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
 
BLUE bluebird bio, Inc.
0.9228
+1.13%
 
IBRX ImmunityBio, Inc.
7.35
+43.84%